Blanchard, Zannel
Brown, Elisabeth A.
Ghazaryan, Arevik
Welm, Alana L. https://orcid.org/0000-0002-1412-1351
Article History
Accepted: 19 November 2024
First Online: 16 December 2024
Competing interests
: The University of Utah may license patient-derived xenograft (PDX) or PDX-derived models made by the Welm laboratory to for-profit companies, which may result in tangible property royalties to the University and members of the Welm laboratory who developed them. A.L.W. has research funding from AbbVie. The remaining authors declare no competing interests.